Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX

Borgeson Blake sold 40,000 Recursion Pharmaceuticals, Inc. shares (Form 4)

Traded Nov 3, 2026 · Filed Nov 4, 2026

On Nov 3, 2026, Borgeson Blake (Director) sold 40,000 Recursion Pharmaceuticals, Inc. shares at US$3.88 for US$155K under a trading plan, leaving 6,068,287 shares. Filed Nov 4, 2026 (Form 4).

Sold
40,000 shares
Price
US$3.88
Value
US$155K
Holding after
6,068,287 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 3, 2026Class A Common StockSale40,000US$3.886,068,287Direct

Source

Download original · View original at SEC

Related